Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 5-year Analysis of the KEEPsAKE 1 and 2 Trials. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s691. https://doi.org/10.25251/pwq1v445